The AntiParkinson Drugs Global Market Report 2023, provides comprehensive information on the antiparkinson drugs market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The AntiParkinson Drugs Market’s Growth:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report
As per The Business Research Company’s AntiParkinson Drugs Global Market Report 2023, the market size is expected to grow from $9.64 billion in 2022 to $10.23 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global anti-parkinson drugs is expected to grow to $12.37 billion in 2027 at a CAGR of 4.9%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
The antiparkinson drugs market is segmented:
1) By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-Inhibitors, Anticholinergics, Other Drugs
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
Top Keyplayers
- GlaxoSmithKline PLC.
- Pfizer
- Merck
- Novartis
- Roche
North America was the largest region in the antiparkinson drugs market in 2022.
The table of contents in TBRC’s antiparkinson drugs market report includes:
- Executive Summary
- Anti-Parkinson Drugs Market Characteristics
- Anti-Parkinson Drugs Market Trends And Strategies
- Anti-Parkinson Drugs Market – Macro Economic Scenario
- Anti-Parkinson Drugs Market Size And Growth
.
- Anti-Parkinson Drugs Pipeline Analysis
- Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market
- Anti-Parkinson Drugs Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
